Compugen (CGEN) Reports In-Line Q4 EPS
Tweet
Share
E-mailGet Alerts CGEN Hot Sheet
Join SI Premium – FREE
Compugen (NASDAQ: CGEN) reported Q4 EPS of ($0.10), in-line with the analyst estimate of ($0.10).
For earnings history and earnings-related data on Compugen (CGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Compugen to Present Phase 1 MAIA-Ovarian Trial-in-Progress Poster at ESMO Gynaecological Cancers Congress 2026
- Deutsche Telekom shares slide as CEO pushes to merge with T-Mobile US
- Honeywell Technologies sets three-year targets ahead of aerospace spin-off
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
